Literature DB >> 19307514

Prospective study of factors predicting adherence to medical advice in men with testicular cancer.

Clare Moynihan1, Andy R Norman, Yolanda Barbachano, Louise Burchell, Robert Huddart, David P Dearnaley, Alan Horwich.   

Abstract

PURPOSE: To identify predictive factors of adherence to medical advice, specifically the likelihood of attendance to a recommended follow-up regimen in patients with newly diagnosed testicular cancer. PATIENTS AND METHODS; This was a prospective study measuring initially not only aspects of the doctor-patient interview, but also a range of demographic, psychological, social, and medical factors, and then recording attendance behavior on follow-up. All 209 new patients with testicular cancer referred between June 1992 and May 1995 were approached, and 184 men consented and completed questionnaires. The nonadherence end point (nonattender) was two failures to attend an outpatient appointment at least 1 month apart, despite a written reminder.
RESULTS: Thirty-two participants (17%) were classified as nonattenders. No significant differences were found between attenders and nonattenders in the majority of psychosocial and medical variables that might have predicted nonadherence to medical advice. There was a highly significant association between nonattendance and a patient's perception of an unsatisfactory affective relationship with his clinician (P = .005; hazard ratio, 3.1; 95% CI, 1.4 to 6.6).
CONCLUSION: Patients who perceived an unsatisfactory affective relationship with their clinician that included an inability to trust the clinician and a perception that they were not being treated as "a person" were subsequently more likely to disregard medical advice regarding follow-up. Attention to the ways young men may wish to communicate with their clinicians is important, bearing in mind that they may not necessarily adhere to stereotypical images of masculine self-dependence.

Entities:  

Mesh:

Year:  2009        PMID: 19307514      PMCID: PMC2738633          DOI: 10.1200/JCO.2008.16.1901

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  31 in total

1.  Do health beliefs predict health behaviour? A follow-up analysis of breast self-examination.

Authors:  M Calnan; D R Rutter
Journal:  Soc Sci Med       Date:  1988       Impact factor: 4.634

2.  Development of a questionnaire measure of adjustment to cancer: the MAC scale.

Authors:  M Watson; S Greer; J Young; Q Inayat; C Burgess; B Robertson
Journal:  Psychol Med       Date:  1988-02       Impact factor: 7.723

3.  Refusal of cancer treatment in testicular cancer patients.

Authors:  J W Moul; D F Paulson; P J Walther
Journal:  J Natl Cancer Inst       Date:  1989-10-18       Impact factor: 13.506

4.  Patient noncompliance with self-administered chemotherapy.

Authors:  A H Lebovits; J J Strain; S J Schleifer; J S Tanaka; S Bhardwaj; M R Messe
Journal:  Cancer       Date:  1990-01-01       Impact factor: 6.860

5.  Treatment experience with nonseminomatous testicular cancer in patients with stage II and stage III disease.

Authors:  H G Taylor; A W Brown; W M Butler; M D Weltz; J L Berenberg; D G McCleod; J E Fowler; R E Stutzman; J Blom
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

6.  Psychological distress and surveillance behaviors of women with a family history of breast cancer.

Authors:  K M Kash; J C Holland; M S Halper; D G Miller
Journal:  J Natl Cancer Inst       Date:  1992-01-01       Impact factor: 13.506

7.  Locus of control and adjustment to cancer.

Authors:  M Watson; J Pruyn; S Greer; B van den Borne
Journal:  Psychol Rep       Date:  1990-02

Review 8.  The Health Belief Model: a decade later.

Authors:  N K Janz; M H Becker
Journal:  Health Educ Q       Date:  1984

9.  Refusal in testicular cancer patients: implications for surveillance.

Authors:  J W Moul
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

10.  Compliance with follow-up of patients treated for non-seminomatous testicular cancer.

Authors:  B J Young; B D Bultz; J A Russell; M S Trew
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

View more
  7 in total

1.  Assessing patient adherence to a complementary medicine treatment regimen in an integrative supportive care setting.

Authors:  Eran Ben-Arye; Dikla Kruger; Noah Samuels; Lital Keinan-Boker; Tamar Shalom; Elad Schiff
Journal:  Support Care Cancer       Date:  2014-03       Impact factor: 3.603

2.  Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors.

Authors:  Xiangdong Li; Shengjie Guo; Zhiming Wu; Pei Dong; Yonghong Li; Zhiling Zhang; Kai Yao; Hui Han; Zike Qin; Fangjian Zhou; Zhuowei Liu
Journal:  World J Urol       Date:  2014-12-04       Impact factor: 4.226

Review 3.  Management of stage I testicular germ cell tumours.

Authors:  Michal Chovanec; Nasser Hanna; K Clint Cary; Lawrence Einhorn; Costantine Albany
Journal:  Nat Rev Urol       Date:  2016-09-13       Impact factor: 14.432

4.  Close ties: an exploratory Colored Eco-Genetic Relationship Map (CEGRM) study of social connections of men in Familial Testicular Cancer (FTC) families.

Authors:  June A Peters; Regina Kenen; Lindsey M Hoskins; Gladys M Glenn; Christian Kratz; Mark H Greene
Journal:  Hered Cancer Clin Pract       Date:  2012-03-01       Impact factor: 2.857

Review 5.  Achieving adolescent adherence to treatment of major depression.

Authors:  Dennis Staton
Journal:  Adolesc Health Med Ther       Date:  2010-08-04

6.  German second-opinion network for testicular cancer: sealing the leaky pipe between evidence and clinical practice.

Authors:  Friedemann Zengerling; Michael Hartmann; Axel Heidenreich; Susanne Krege; Peter Albers; Alexander Karl; Lothar Weissbach; Walter Wagner; Jens Bedke; Margitta Retz; Hans U Schmelz; Sabine Kliesch; Markus Kuczyk; Eva Winter; Tobias Pottek; Klaus-Peter Dieckmann; Andres Jan Schrader; Mark Schrader
Journal:  Oncol Rep       Date:  2014-04-24       Impact factor: 3.906

7.  Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.

Authors:  J Beyer; P Albers; R Altena; J Aparicio; C Bokemeyer; J Busch; R Cathomas; E Cavallin-Stahl; N W Clarke; J Claßen; G Cohn-Cedermark; A A Dahl; G Daugaard; U De Giorgi; M De Santis; M De Wit; R De Wit; K P Dieckmann; M Fenner; K Fizazi; A Flechon; S D Fossa; J R Germá Lluch; J A Gietema; S Gillessen; A Giwercman; J T Hartmann; A Heidenreich; M Hentrich; F Honecker; A Horwich; R A Huddart; S Kliesch; C Kollmannsberger; S Krege; M P Laguna; L H J Looijenga; A Lorch; J P Lotz; F Mayer; A Necchi; N Nicolai; J Nuver; K Oechsle; J Oldenburg; J W Oosterhuis; T Powles; E Rajpert-De Meyts; O Rick; G Rosti; R Salvioni; M Schrader; S Schweyer; F Sedlmayer; A Sohaib; R Souchon; T Tandstad; C Winter; C Wittekind
Journal:  Ann Oncol       Date:  2012-11-14       Impact factor: 32.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.